Hazard function analysis of prognosis after recurrent colorectal cancer

Background and objectives Mean survival time (MST) is used as the indicator of prognosis in patients with a colorectal cancer (CRC) recurrence. The present study aimed to visualize the changes in death risk after a CRC recurrence using hazard function analysis (HFA) to provide an alternative prognos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Langenbeck's archives of surgery 2024-04, Vol.409 (1), p.123-123, Article 123
Hauptverfasser: Ise, Ichiro, Kawai, Kazushige, Nakano, Daisuke, Takao, Misato, Natsume, Soichiro, Kato, Hiroki, Nakamori, Sakiko, Dejima, Akira, Yamaguchi, Tatsuro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and objectives Mean survival time (MST) is used as the indicator of prognosis in patients with a colorectal cancer (CRC) recurrence. The present study aimed to visualize the changes in death risk after a CRC recurrence using hazard function analysis (HFA) to provide an alternative prognostic indicator to MST. Methods The medical records of 725 consecutive patients with a recurrence following R0 radical surgery for CRC were retrospectively reviewed. Results The five-year, post-recurrence survival rate was 37.8%, and the MST was 3.5 years while the risk of death peaked at 2.9 years post-recurrence. Seven variables were found to predict short-term survival, including the number of metastatic organs ≥ 2, non-surgical treatment for the recurrence, and a short interval before recurrence. In patients with a recurrence in one organ, the MST was four years, the peak time of death predicted by HFA was 2.9 years, and the five-year survival rate was 45.8%. In patients with a surgical resection of the recurrence, the MST was 8 years, the peak time of death was 3.3 years, and the five-year survival rate was 62%. Conclusions The present study established a novel method of assessing changes in mortality risk over time using HFA in patients with a CRC recurrence.
ISSN:1435-2451
1435-2443
1435-2451
DOI:10.1007/s00423-024-03308-w